ORCL
Oracle Corporation
NYSE: ORCL · TECHNOLOGY · SOFTWARE - INFRASTRUCTURE
$184.13
+0.02% today
Updated 2026-06-12
Market cap
$703.42B
P/E ratio
43.99
P/S ratio
10.98x
EPS (TTM)
$5.56
Dividend yield
0.81%
52W range
$135 – $343
Volume
26.1M
Oracle Corporation (ORCL) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Research-backed ORCL price target 2030 projection accounting for share dilution, balance sheet debt, and time value of money.
Current price
$184.13
Today
Analyst consensus
$261.46
+42.00% · 12M
2030 Base
$454.25
+146.70% future
NPV today
$260.71
@ 13% WACC
42 analysts:
32 Buy9 Hold1 Sell
Management guidance
Oracle raised FY2027 revenue guidance to $90.61B (32.09% YoY growth from FY2026 $68.60B). CEO Safra Catz emphasized record $553B in Remaining Performance Obligations (RPO), indicating multi-year contracted backlog to support sustained high growth. Company explicitly targets AI infrastructure as primary growth driver with 84% IaaS revenue growth in Q3 FY2026—first >20% combined revenue/EPS growth in 15 years.
Sources: Management guidance, analyst consensus, sector analysishigh confidence
ORCL · Oracle Corporation · Revenue & price projection · 2023–2030E
Actual / 2030 target Projected revenue Base case price Bull to bear range
Bear case (2030)
$219.14
NPV today: $125.77
Base case (2030)
$454.25
NPV today: $260.71
Bull case (2030)
$630.57
NPV today: $361.90
WallStSmart.com
ORCL financial forecast · Research-backed projections
| Metric | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) ★ |
|---|---|---|---|---|---|---|
| Revenue | $57.4B | $68.6B | $90.6B | $117.0B | $145.0B | $174.0B |
| Revenue growth | 8.4% | 19.5% | 32.1% | 29.0% | 23.9% | 20.0% |
| Net margin | — | 32.2% | 26.0% | 24.9% | 23.3% | 22.2% |
| EPS | $3.73 | $7.63 | $8.09 | $9.95 | $11.45 | $13.05 |
| Diluted shares | — | 2896M | 2914M | 2931M | 2946M | 2960M |
| Net debt | — | $98.01B | $89.27B | $77.99B | $64.02B | $47.24B |
| P/S multiple | — | 8.0x | 8.0x | 8.0x | 8.0x | 8.0x |
| Implied price (base) | — | $155.65 | $218.16 | $292.73 | $372.06 | $454.25 |
★ 2030E is the model's terminal target year. Implied price = (Revenue × P/S − Net debt) ÷ Diluted shares.
Scenario detail · Three drivers, three outcomes
| 2030E driver | Bear | Base | Bull |
|---|---|---|---|
| Revenue | $174.0B | $174.0B | $174.0B |
| P/S multiple | 4.0x | 8.0x | 11.0x |
| Diluted shares | 2960M | 2960M | 2960M |
| Net debt | $47.24B | $47.24B | $47.24B |
| Implied P/E † | 17x | 35x | 48x |
| 2030 Price | $219.14 | $454.25 | $630.57 |
| NPV @ 13% | $125.77 | $260.71 | $361.90 |
† Implied P/E: Multiples remain elevated across all three scenarios because ORCL is valued primarily on revenue scale during its growth phase, not near-term earnings power. Lower P/E in the bear case reflects multiple compression, but the absolute level stays high since 2030E still represents a hypergrowth-to-mature transition year.
EV to per-share bridge · How we get to $454.25 base case
ORCL catalysts and risks
Growth catalysts
+ Record $553B RPO backlog conversion (multi-year AI contracts with hyperscalers: OpenAI, Meta, Nvidia, Microsoft, government agencies)
+ Oracle Cloud Infrastructure (OCI) gaining market share vs AWS/Azure; 84% IaaS growth YoY demonstrates traction with AI-intensive workloads
+ Massive 2026 Vera CPU rollout to major customers; AI infrastructure capex cycle accelerating through 2028 (hyperscaler combined >$300B annual AI capex)
+ Margin expansion from restructuring/workforce optimization; improved FCF despite elevated capex
+ Potential government AI contracts and defense sector expansion (Cleveland Clinic CEO added to board signals healthcare AI)
Key risks
- High capex requirements for OCI buildout compete with shareholder returns; negative FCF in recent quarters despite revenue growth
- AI infrastructure market remains competitive (AWS, Azure, Google Cloud); Oracle's late entry vs established hyperscaler clouds
- Debt/Equity ratio at 4.21x; increased leverage from AI infrastructure investments may constrain financial flexibility
- Revenue recognition timing risk: large multi-year AI contracts front-loaded in backlog; actual cash conversion may lag revenue recognition
- Hyperscaler capex cycles unpredictable; potential slowdown in AI spending would directly impact OCI growth trajectory
Methodology · Oracle Corporation 2030 stock forecast model
Oracle Corporation 2030 price target is calculated using WallStSmart's research model. Revenue projections are derived from analyst consensus across 42 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts. The model is built on five core components:
| 1. Share dilution | Projected from per-ticker schedule of SBC + equity raise activity, compounding year by year (3% cumulative for ORCL by 2030) |
| 2. Net debt | EV minus net debt yields equity value; debt projected from capex cycle trajectory ($47.24B by 2030) |
| 3. Time value | NPV calculated using 13% WACC (sector fallback) |
| 4. Multiple framework | P/S compresses with scale: bear 4.0x / base 8.0x / bull 11.0x |
| 5. Scenario design | Bull/Base/Bear vary revenue, margin, shares, debt, and multiple independently |
WallStSmart research model · Not financial advice · Past performance is not indicative of future results · Last researched: May 20, 2026.
ORCL price target FAQ
What is the ORCL price target for 2030?
WallStSmart's Oracle Corporation 2030 base case is $454.25 per share, with a bull case of $630.57 and bear case of $219.14. The NPV of the base case discounted to today at 13% WACC is $260.71.
How is the Oracle Corporation 2030 stock forecast calculated?
The ORCL 2030 projection multiplies projected revenue by a growth-adjusted P/S multiple to derive enterprise value, subtracts projected net debt to get equity value, then divides by diluted shares outstanding accounting for dilution from stock-based compensation and equity raises.
Why does the ORCL price target account for dilution?
Oracle Corporation is projected to grow diluted share count from 2876M to 2960M by 2030 (a 3% increase) through stock-based compensation and capital raises. Ignoring this would inflate the price target by approximately 3%.
What is the analyst consensus on ORCL stock?
42 analysts cover ORCL with an average 12-month price target of $261.46. The 2030 projection extends this framework with longer-horizon assumptions including dilution and time value of money.